Form EFFECT Silexion Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 15, 2025 5:15 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Health-E Commerce® Expands Beyond E-Commerce with Launch of Patiently™ Telehealth Platform Offering Personalized, FSA/HSA Eligible Weight Loss and Menopause Support
- Cycurion Lands Largest Contract in Company History: $54.6 Million 10-Year Award with Top-5 Global Consulting Firm
- Therma Bright Inc. Completes Debt Settlements
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
